Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
SPHS

Sophiris Bio

$2.56

-0.0337 (-1.30%)

06:00
04/19/17
04/19
06:00
04/19/17
06:00
Conference/Events
Sophiris Bio management to meet with Needham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Apr

SPHS

Sophiris Bio

$2.87

0.29 (11.24%)

09:02
03/27/17
03/27
09:02
03/27/17
09:02
Earnings
Sophiris Bio reports Q4 EPS (2c), consensus (11c) »

At December 31, 2016, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Apr

Over a month ago
MU

Micron

$26.47

0.41 (1.57%)

, KBH

KB Home

$19.32

0.21 (1.10%)

17:39
03/23/17
03/23
17:39
03/23/17
17:39
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS: Micron…

MU

Micron

$26.47

0.41 (1.57%)

KBH

KB Home

$19.32

0.21 (1.10%)

SNAK

Inventure Foods

$4.04

0.05 (1.25%)

SPHS

Sophiris Bio

$2.58

0.03 (1.18%)

QTNT

Quotient

$6.50

-0.13 (-1.96%)

RXDX

Ignyta

$8.90

0.45 (5.33%)

GME

GameStop

$23.96

-0.13 (-0.54%)

SPWH

Sportsman's Warehouse

$5.03

0.37 (7.94%)

OXM

Oxford Industries

$53.46

0.97 (1.85%)

MYL

Mylan

$41.61

-0.095 (-0.23%)

TRNC

tronc

$13.16

-0.23 (-1.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Mar

  • 23

    Mar

  • 23

    Mar

  • 23

    Mar

  • 23

    Mar

  • 24

    Mar

  • 28

    Mar

  • 30

    Mar

  • 06

    Apr

  • 19

    Apr

  • 06

    Jun

  • 03

    Sep

  • 09

    Oct

  • 24

    Mar

SPHS

Sophiris Bio

$2.58

0.03 (1.18%)

17:24
03/23/17
03/23
17:24
03/23/17
17:24
Hot Stocks
Sophiris Bio to present 'successful' topsalysin Phase 2 data at AEAU »

Sophiris Bio announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Apr

CHEK

Check-Cap

$2.24

-0.02 (-0.88%)

, LMAT

LeMaitre

$22.87

0.16 (0.70%)

09:15
02/02/17
02/02
09:15
02/02/17
09:15
Conference/Events
PR Newswire to hold a virtual conference »

VirtualInvestorConferences…

CHEK

Check-Cap

$2.24

-0.02 (-0.88%)

LMAT

LeMaitre

$22.87

0.16 (0.70%)

DRIO

DarioHealth

$3.52

-0.0317 (-0.89%)

GALT

Galectin Therapeutics

$1.01

0.02 (2.02%)

TPIV

TapImmune

$4.27

0.09 (2.15%)

SPHS

Sophiris Bio

$2.84

-0.05 (-1.73%)

IGXT

IntelGenx

$0.83

0.0078 (0.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Feb

  • 13

    Feb

  • 15

    Feb

  • 21

    Mar

  • 29

    Mar

CHEK

Check-Cap

$2.24

-0.02 (-0.88%)

, LMAT

LeMaitre

$22.87

0.16 (0.70%)

07:29
02/02/17
02/02
07:29
02/02/17
07:29
Conference/Events
PR Newswire to hold a virtual conference »

VirtualInvestorConferences…

CHEK

Check-Cap

$2.24

-0.02 (-0.88%)

LMAT

LeMaitre

$22.87

0.16 (0.70%)

DRIO

DarioHealth

$3.52

-0.0317 (-0.89%)

GALT

Galectin Therapeutics

$1.01

0.02 (2.02%)

TPIV

TapImmune

$4.27

0.09 (2.15%)

SPHS

Sophiris Bio

$2.84

-0.05 (-1.73%)

IGXT

IntelGenx

$0.83

0.0078 (0.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Feb

  • 13

    Feb

  • 15

    Feb

  • 21

    Mar

  • 29

    Mar

Over a quarter ago
AFMD

Affimed NV

$2.15

-0.15 (-6.52%)

, BPTH

Bio-Path Holdings

$1.28

-0.03 (-2.29%)

07:52
11/29/16
11/29
07:52
11/29/16
07:52
Conference/Events
Oppenheimer to hold a summit »

Life Sciences Summit is…

AFMD

Affimed NV

$2.15

-0.15 (-6.52%)

BPTH

Bio-Path Holdings

$1.28

-0.03 (-2.29%)

CHMA

Chiasma

KURA

Kura Oncology

$5.05

-0.3 (-5.61%)

EIGR

Eiger BioPharmaceuticals

$12.50

-0.5 (-3.85%)

MRNS

Marinus Pharmaceuticals

$1.11

-0.05 (-4.31%)

NERV

Minerva

$13.55

-0.45 (-3.21%)

OVAS

OvaScience

$3.58

-0.19 (-5.04%)

SCLN

SciClone

$10.25

0.05 (0.49%)

SPHS

Sophiris Bio

$2.70

-0.14 (-4.93%)

TLGT

Teligent

$7.36

-0.15 (-2.00%)

XNCR

Xencor

$26.00

-1.17 (-4.31%)

ZYNE

Zynerba

$13.62

-0.42 (-2.99%)

ZGNX

Zogenix

$12.70

-0.6 (-4.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

  • 29

    Nov

  • 29

    Nov

  • 02

    Dec

  • 03

    Dec

SPHS

Sophiris Bio

$2.85

0.04 (1.42%)

08:24
09/15/16
09/15
08:24
09/15/16
08:24
Initiation
Sophiris Bio initiated at Roth Capital »

Sophiris Bio initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRBP

Corbus Pharmaceuticals

$4.20

0.11 (2.69%)

, SPHS

Sophiris Bio

$2.94

-0.04 (-1.34%)

08:30
09/02/16
09/02
08:30
09/02/16
08:30
Options
Two new option listings and three option delistings on September 2nd »

New option listings for…

CRBP

Corbus Pharmaceuticals

$4.20

0.11 (2.69%)

SPHS

Sophiris Bio

$2.94

-0.04 (-1.34%)

AMTG

Apollo Residential Mortgage

MCPIQ

Molycorp

TLMR

Acquired by CHFC

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPHS

Sophiris Bio

$3.37

-0.15 (-4.26%)

05:36
08/30/16
08/30
05:36
08/30/16
05:36
Initiation
Sophiris Bio initiated at Piper Jaffray »

Sophiris Bio initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.